Chandler and Grant's Glaucoma, Sixth Edition

Malik Y Kahook, MD ; Joel S Schuman, MD

  • $249.95
  • ISBN 10 1630914657
  • ISBN 13 978-1630914653
  • 750 pp Hard Cover
  • Due: December 2020
  • Order# 64653

Chandler and Grant’s Glaucoma—one of the field’s seminal texts on the medical practice and surgical management of glaucoma, now in its Sixth Edition—includes the latest updates in an area that is currently experiencing a surge of innovation.

Edited by Drs. Malik Y. Kahook and Joel S. Schuman and with contributions from the late David L. Epstein and more than 80 contributors, Chandler and Grant’s Glaucoma, Sixth Edition brings together the experience of world-class glaucoma experts who belong to a long line of surgeons trained using the teachings of the original authors of this classic work.

Each chapter has been meticulously edited and updated from the previous edition, while maintaining the well-established historical teachings of Drs. Paul A. Chandler and W. Morton Grant. New chapters on medical therapy as well as thorough updates on novel and minimally invasive approaches for the surgical management of glaucoma have been added.

New topics and features in the Sixth Edition include:

  • Advances in imaging of the optic nerve and retina
  • Rho-associated protein kinase (ROCK) inhibitors
  • Glaucoma and cerebrospinal fluid pressure
  • The US Food and Drug Administration’s role in the development of new diagnostic and surgical devices for patients with glaucoma

Chandler and Grant’s Glaucoma has been the most relevant and invaluable reference on glaucoma for generations of ophthalmologists. This updated Sixth Edition builds on the teachings of previous editions, making the Sixth Edition as relevant in the 21st century as when the first lectures were presented by Drs. Chandler and Grant more than 55 years ago.

About the Editors
Contributing Authors
A Look Back to the Preface of the Fifth Edition
Preface to the Sixth Edition

Section I: The Basics
Chapter 1: Introduction
Chapter 2: Anatomy
Chapter 3: Practical Aqueous Humor Dynamics
Chapter 4: The Patient’s History: Symptoms of Glaucoma
Chapter 5: Examination of the Eye
Chapter 6: Tonometry and Tonography
Chapter 7: The Angle of the Anterior Chamber
Chapter 8: Examination of the Optic Nerve
Chapter 9: Imaging the Optic Nerve Head, Peripapillary and Macula Regions in Glaucoma
Chapter 10: Imaging Devices for Angle Assessment
Chapter 11: Visual Fields and Their Relationship to the Optic Nerve

Section II: Medications Used in Glaucoma Therapy
Chapter 12: Adrenergic Agents: Blockers and Agonists
Chapter 13: The Miotics
Chapter 14: Carbonic Anhydrase Inhibitors: Systemic Use
Chapter 15: Topical Carbonic Anhydrase Inhibitors
Chapter 16: Prostaglandin Analogs
Chapter 17: Rho-Associated Protein Kinase Inhibitors and Primary Open-Angle Glaucoma
Chapter 18: Management of Highly Elevated Intraocular Pressure

Section III: Common Open-Angle Glaucomas
Chapter 19: Primary Open-Angle Glaucoma
Chapter 20: Normal-Tension Glaucoma
Chapter 21: Pseudoexfoliation Syndrome and Open-Angle Glaucoma
Chapter 22: Pigment Dispersion and Pigmentary Glaucoma

Section IV: Angle-Closure Glaucomas
Chapter 23: Principles of Primary Angle-Closure Glaucoma
Chapter 24: Acute Angle-Closure Glaucoma: Diagnosis and Treatment
Chapter 25: Subacute (and Chronic) Angle-Closure Glaucoma
Chapter 26: Angle-Closure Glaucoma: Evaluation and Treatment After Iridotomy
Chapter 27: Plateau Iris
Chapter 28: The Use of Special Tests in Narrow-Angled Eyes

Section V: Secondary Angle-Closure Glaucomas
Chapter 29: Principles of Secondary Angle-Closure Glaucomas
Chapter 30: The Malignant Glaucoma Syndromes
Chapter 31: Nanophthalmos: Diagnosis and Treatment
Chapter 32: Neovascular Glaucoma
Chapter 33: Iridocorneal Endothelial Syndrome
Chapter 34: Glaucoma After Vitreoretinal Procedures
Chapter 35: Angle-Closure Glaucoma Due to Multiple Cysts of the Iris and Ciliary Body
Chapter 36: Angle-Closure Glaucoma Secondary to Occlusion of the Central Retinal Vein
Chapter 37: Angle-Closure Glaucoma Secondary to Acute Myopia
Chapter 38: Glaucoma After Penetrating Keratoplasty

Section VI: Combined Mechanisms
Chapter 39: Combined Open-Angle and Angle-Closure Glaucoma
Chapter 40: Glaucoma in the Pseudophakic and Aphakic Eye
Chapter 41: Characteristically Unilateral Glaucomas: Differential Diagnosis
Chapter 42: Glaucoma Secondary to Intraocular Tumors

Section VII: Secondary Open-Angle Glaucoma
Chapter 43: Glaucoma Due to Intraocular Inflammation
Chapter 44: Glaucoma Due to Trauma
Chapter 45: Corticosteroid Glaucoma
Chapter 46: Hemolytic or Ghost-Cell Glaucoma
Chapter 47: Glaucoma Associated With Extraocular Venous Congestion (Increased Episcleral Venous Pressure)
Chapter 48: Lens-Induced Glaucoma
Chapter 49: Amyloidosis and Open-Angle Glaucoma
Chapter 50: Glaucoma in the Phakomatoses
Chapter 51: Juvenile Open-Angle Glaucoma

Section VIII: Laser Methods in Glaucoma
Chapter 52: Glaucoma Laser Surgery
Chapter 53: Laser Trabeculoplasty
Chapter 54: Laser Trabeculoplasty: How Does It Work?
Chapter 55: Post-Laser Elevation of Intraocular Pressure
Chapter 56: Laser Peripheral Iridotomy
Chapter 57: Cyclodestruction
Chapter 58: Laser Peripheral Iridoplasty

Section IX: Glaucoma Surgery
Chapter 59: What to Say to Patients With Glaucoma Prior to Filtration Surgery
Chapter 60: Filtering Surgery in the Management of Glaucoma
Chapter 61: Postoperative Management Following Filtration Surgery
Chapter 62: The Management of Coexisting Cataract and Glaucoma
Chapter 63: Aqueous Shunting Procedures
Chapter 64: Cyclodialysis
Chapter 65: Surgical Peripheral Iridectomy
Chapter 66: Schlemm’s Canal Surgery for Glaucoma Management
Chapter 67: Suprachoroidal Approach to Glaucoma Surgery
Chapter 68: Treatment of Occludable Angles and Angle Closure With Cataract Extraction

Section X: Diagnosis and Treatment of Glaucoma in Children
Chapter 69: Pediatric Glaucoma
Chapter 70: Unusual Pediatric Glaucomas

Section XI: Special Considerations
Chapter 71: The Role of the Cornea in Managing Glaucoma
Chapter 72: Twenty-Four–Hour Intraocular Pressure Monitoring in Glaucoma
Chapter 73: The Role of Ocular Perfusion Pressure in the Pathogenesis of Glaucoma
Chapter 74: Glaucoma and Cerebrospinal Fluid Pressure
Chapter 75: Neuroprotection in Glaucoma
Chapter 76: Adherence to Glaucoma Medical Therapy
Chapter 77: FDA’s Role in the Development of New Diagnostic and Surgical Devices for Patients With Glaucoma in the United States

Financial Disclosures

Malik Y. Kahook, MD is Professor of Ophthalmology and Director of Clinical and Translational Research in the Department of Ophthalmology at the University of Colorado. He also directs the glaucoma service and glaucoma fellowship. Dr. Kahook specializes in the medical and surgical treatment of glaucoma and cataracts. He is active within the ophthalmology community, including memberships in the American Academy of Ophthalmology, American Glaucoma Society, American Society of Refractive and Cataract Surgeons, and the Association for Research in Vision and Ophthalmology. Dr. Kahook has authored more than 200 peer-reviewed manuscripts, abstracts, and book chapters, and is editor of 4 textbooks, including Essentials of Glaucoma Surgery (SLACK Incorporated). He is on the editorial board of the American Journal of Ophthalmology and International Glaucoma Review, among others. He was awarded an American Glaucoma Society Clinician-Scientist Fellowship Award for 2007, as well as the American Glaucoma Society Compliance Grant for 2006, and was named New Inventor of the Year for the University of Colorado in 2009 and Inventor of the Year for 2010. Dr. Kahook received the American Academy of Ophthalmology Achievement Award in 2011. He has filed for more than 12 patents, several of which have been licensed by companies for development and commercialization. He currently serves as a consultant to the US Food and Drug Administration’s Ophthalmic Device Division. 
 Dr. Kahook completed his residency training at the University of Colorado, Rocky Mountain Lions Eye Institute in Denver, Colorado, where he was named Chief Resident. He then went on to complete his fellowship in glaucoma from the University of Pittsburgh Medical Center in Pittsburgh, Pennsylvania.

Joel S. Schuman, MD, FACS is the Eye and Ear Foundation Professor and Chairman of Ophthalmology, the Eye and Ear Institute, University of Pittsburgh School of Medicine and Director of the University of Pittsburgh Medical Center (UPMC) Eye Center. He is also Professor of Bioengineering at the Swanson School of Engineering, University of Pittsburgh, and a Founder of the Louis J. Fox Center for Vision Restoration of UPMC and the University of Pittsburgh. He is a member of the McGowan Institute for Regenerative Medicine and the Center for the Neural Basis of Cognition, Carnegie Mellon University and University of Pittsburgh. Dr. Schuman is a native of Roslyn, New York; he graduated from Columbia University (BA, 1980) and Mt. Sinai School of Medicine (MD, 1984). Following his internship at New York’s Beth Israel Medical Center (1985), he completed residency training at Medical College of Virginia (1988) and glaucoma fellowship at Massachusetts Eye & Ear Infirmary (clinical 1989; research 1990), where he was a Heed Fellow. After just over a year on the Harvard faculty, he moved to the New England Medical Center, Tufts University, to co-found the New England Eye Center in 1991, where he was Residency Director and Glaucoma and Cataract Service Chief. In 1998, he became Professor of Ophthalmology, and Vice Chair in 2001.

Dr. Schuman and his colleagues were the first to identify a molecular marker for human glaucoma, as published in Nature Medicine in 2001. He has been continuously funded by the National Eye Institute as a principal investigator since 1995, is principal investigator of a National Institutes of Health (NIH) grant to study novel glaucoma diagnostics, and is co-investigator of NIH grants for research into novel optical diagnostics and short pulse laser surgery and for advanced imaging in glaucoma. He is an inventor of optical coherence tomography (OCT), used world-wide for ocular diagnostics. Dr. Schuman has published more than 250 peer-reviewed scientific journal articles, has authored or edited 8 books, and has contributed more than 50 book chapters.

In 2002, Dr. Schuman received the Alcon Research Institute Award, as well as the New York Academy of Medicine’s Lewis Rudin Glaucoma Prize. In 2003, he received the Senior Achievement Award from the American Academy of Ophthalmology. In 2004, he was elected into the American Society for Clinical Investigation. In 2006, he received the Association for Research in Vision and Ophthalmology (ARVO) Translational Research Award. He was elected to the American Ophthalmological Society in 2008. He received a 2006-2009 American Medical Association Physician’s Recognition Award with Commendation. In 2010, he became a silver Fellow of ARVO. In 2011, Dr. Schuman was the Clinician-Scientist Lecturer of the American Glaucoma Society. In 2012, he received the Carnegie Science Center’s Award in Life Sciences and was a co-recipient of the Champalimaud Award.

Sign up to receive

Book E-mail alerts

(no third party emails)